Integrated Animal Health announced today that it will locate its North American headquarters and commercial operations in the KC Animal Health Corridor. The Queensland, Australia-based animal health company also announced it has named Blake Hawley, DVM, MBA as North American president & CEO to manage the growth of the company’s global product lines.
“After attending the 2014 Homecoming event we knew that the KC Animal Health Corridor was the ideal location to establish Integrated Animal Health’s North American presence and grow our product lines globally,” said Rob Neely, CEO, Integrated Animal Health.
Integrated Animal Health, Inc. will announce additional key hires in the coming months and will identify a permanent Corridor office location by the end of summer 2015.
“Integrated Animal Health is an extraordinary and disruptive animal health company. We look forward to being an active player in the KC Animal Health Corridor making a global impact on animal health through our strategic partnerships,” said Hawley.
“The Homecoming dinner has become the KC Animal Health Corridor’s most powerful hosting opportunity, as evidenced by today’s announcement from Integrated Animal Health,” said Kimberly Young, president, KC Animal Health Corridor. “The concentration of industry leadership and influence can’t be matched and is most evident when the industry comes together every year in KC for Homecoming and the Investment Forum.”
Integrated Animal Health (IAH) is a privately owned and funded Australian company. IAH began by developing World First Animal Health products based on the patented human TPM® Delivery Technology, which delivers nutraceuticals and also drugs both orally and through the skin. Notably, in 2014, IAH delivered Oxycodone in a World First via a TPM®/Oxycodone topical patch to provide quick pain relief to thoroughbred racehorses with shin soreness.
Integrated Animal Health is now known for its unique ability to identify early stage disruptive technology. IAH is now developing and trialing over 70 products including a natural oral tick and fly repellents for use in the cattle feedlot industry with companion animals to follow. They are also working on non-mechanical X/Y Sperm selection technology for the Hog and Dairy industries.
Integrated Animal Health’s core strategy has been to identify difficult to deliver compounds that have already demonstrated safety and efficacy in humans and to develop non-therapeutics for feed chain animals, companion animals or performance animals around the world. One of their biggest commercial achievements to date has been a natural application that has shown to decrease antibiotic use by 50% in clinical mastitis in dairy cows, such is the importance of this technology IAH are now in commercial discussions with several Top 10 Global Dairy Companies.
Integrated Animal Health’s business model is to out-license and partner its technologies for separate species and territories globally.
Mastitis Management Australia, Equine Ergogenics Australia and Veterinary Research Australia amalgamated to become Integrated Animal Health in December 2013 and incorporated February 2014. integrated-animal-health.com